The proportion of gp130+ cells was significantly higher in CD3+CD4+ compared with CD3+CD4─ and CD3─CD4─ populations in both healthy controls (Figure 3A) and SLE patients (Figure 3B) (p<0.001 for all comparisons). This evidence concerns the gene CD4 and systemic lupus erythematosus.